Invent new platforms for
With our extensive experiences of drug development from CRO business and unique global network covering Asia, Africa, and Australia. Along with the development of systems such as EDC, e-Consent, ePRO, and CTMS brought us a vision of DCT (Decentralized Clinical Trials;).
By combining each competence, we will invent new platforms for drug development.
We continue to support innovative pharmaceuticals and drug developments to improve the world and clinical trial environments.
Remedy & Company Corporation is committed to invent an innovative global clinical trial environment to solve challenges such as welfare, education, and health science.
Notice: Regarding Remedy & Company's Exhibit
Remedy & Company Corporation joins to GHIT Fund, a Public Interest Incorporated Association, as an Associate Partner.
Global Newsletter New Release "Latin America, a region of opportunities to conduct Clinical Trials."(This will open in a new window.)
Global development with a focus on Asia, and the latest information on regenerative medicine.
Regenerative Medicine Column
ISSCR Special Edition:Regenerative Medicine and list of Regenerative Medicine Products Approved in Japan
This article is a special edition of the Regenerative Medicine Column distributed at the ISSCR Tokyo International Symposium 2021 held in October 2021. It introduces Remedy's Approach to Regenerative Medicine and list of Regenerative Medicine Products Approved in Japan.
- Regenerative Medicine Product
Volume of importing medical devices and updated medical device regulations in Thailand
According to the Plastic Institute of Thailand, Thailand's medical device imports grew by about 23% in the 2Q of 2021. And is expected to average 6.5% per year due to the aging of the population, rising demand for healthcare.
- Medical Equipment
We are looking for talents who are willing to take on challenges with us in the world.
Remedy Group is always looking for talents who share our philosophy, result oriented and are willing to challence to world.